Prellis Biologics
Prellis Biologics is developing technology to build transplantable human organs and tissues.
6
Funding Rounds
$88.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Me***** Ma**** | - | - | linkedin twitter |
| No**** Mu**** | - | - | linkedin twitter facebook |
Funding
Funding series
Funding Series Analysis
The company Prellis Biologics has raised a total of $58.2m in funding over 6 rounds.
Key Insights:
- Prellis Biologics Series C round, August 10, 2022: $35m
- Prellis Biologics Series B round, December 2021: $14.5m
- Prellis Biologics Series A round, July 2019: $8.7m
- Prellis Biologics funding round, September 2017: $1.8m
- Prellis Biologics funding round, August 2019: $8.7m
- Prellis Biologics, Inc funding round, July 2021: $19.25m
Prellis Biologics Series C round, August 10, 2022
$35m
Prellis Biologics Series B round, December 2021
$14.5m
Prellis Biologics Series A round, July 2019
$8.7m
Prellis Biologics funding round, September 2017
$1.8m
Prellis Biologics funding round, August 2019
$8.7m
Prellis Biologics, Inc funding round, July 2021
$19.25m
Industries
Prellis Biologics is active in the following industries:
- Medicine
- Biology
- Technology
- Synthetic biology
- Regenerative medicine
- Pharmaceutical industry
- Organ transplantation
- Engineering
- 3D printing
- Healthcare
- Biomedical engineering
- Tissue engineering
- Bioprinting
- Biotechnology